Professor Jae-Byum Chang and Professor Yeon Sik Jung's joint research team of the Department of Materials Science and ...

Pfizer Inc. today announced positive topline results from its pivotal Phase 3 CREST trial evaluating sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination with Bacillus ...

UCB, a global biopharmaceutical company, and XtalPi, a global leader in AI drug discovery, today announced a license agreement ...